IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2017 | $39,799 | | property tax abatement |
Novartis Pharmaceuticals Corporation | Novartis | Maryland | state | 2009 | $39,846 | | tax credit/rebate |
Moderna Therapeutics, Inc | Moderna Inc. | Massachusetts | state | 2012 | $40,000 | | tax credit/rebate |
Incyte Corporation | Incyte Corp. | Maryland | state | 2020 | $40,117 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2004 | $40,481 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2015 | $40,702 | | property tax abatement |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2020 | $41,168 | | tax credit/rebate |
IDEXX OPERATIONS INC | IDEXX Laboratories | Maine | state | 2016 | $41,242 | | property tax abatement |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2021 | $41,307 | | tax credit/rebate |
TEVA Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2009 | $41,319 | | tax credit/rebate |
AMRI BOTHELL RESEARCH CENTER INC | Curia Inc. | Washington | state | 2012 | $41,418 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2013 | $41,681 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2014 | $41,681 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2015 | $41,681 | | tax credit/rebate |
GILEAD SCIENCES INC | Gilead Sciences | Washington | state | 2016 | $41,681 | | tax credit/rebate |
Mylan Technologies | Viatris | Vermont | state | 2011 | $41,813 | | training reimbursement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2006 | $41,965 | | tax credit/rebate; property tax abatement |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2010 | $42,015 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2017 | $42,107 | | tax credit/rebate |
UCB, Inc. | UCB | North Carolina | state | 2013 | $42,180 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2006 | $42,228 | | tax credit/rebate; property tax abatement |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2012 | $42,268 | | tax credit/rebate |
United Therapeutics Corporation & Subs. | United Therapeutics | Maryland | state | 2014 | $42,268 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2011 | $42,682 | | tax credit/rebate |
Pfizer Inc & Subsidiaries | Pfizer | Maryland | state | 2019 | $42,853 | | tax credit/rebate |
Depuy Spine, Inc. | Johnson & Johnson | Massachusetts | state | 2013 | $43,223 | | tax credit/rebate |
Eon Labs, Inc. | Novartis | North Carolina | state | 2013 | $43,359 | | tax credit/rebate |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2009 | $43,637 | | tax credit/rebate |
Millipore Corporation | Merck KGaA (EMD) | New Hampshire | state | 2008 | $43,842 | | training reimbursement |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2007 | $43,943 | | training reimbursement |
Luitpold Pharmaceuticals | Daiichi Sankyo | New York | local | 2007 | $44,033 | | tax credit/rebate; property tax abatement |
OMEROS CORP | Omeros Corp. | Washington | state | 2012 | $44,191 | | tax credit/rebate |
OMEROS CORP | Omeros Corp. | Washington | state | 2013 | $44,191 | | tax credit/rebate |
Novozymes Biologicals, Inc. | Novo Holdings A/S | Virginia | state | 2010 | $44,312 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2013 | $44,364 | | tax credit/rebate |
Supernus Pharmaceuticals, Inc. | Supernus Pharmaceuticals | Maryland | state | 2018 | $44,733 | | training reimbursement |
BEN VENUE LABORATORIES INC | Boehringer Ingelheim | Ohio | state | 2009 | $45,000 | | grant |
AMYLIN OHIO LLC | AstraZeneca | Ohio | state | 2012 | $45,000 | | grant |
Biogen Idec MA, Inc. | Biogen | North Carolina | state | 2012 | $45,000 | | tax credit/rebate |
Blueprint Medicines Corp | Blueprint Medicines | Massachusetts | state | 2013 | $45,000 | | tax credit/rebate |
Schering-Plough Animal Health Corporation | Merck | Delaware | state | 2008 | $45,400 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | Maryland | state | 2017 | $45,454 | | tax credit/rebate |
JOHNSON & JOHNSON HEALTH CARE SYSTEMS INC | Johnson & Johnson | Tennessee | local | 2013 | $45,482 | | property tax abatement |
JOHNSON & JOHNSON HEALTH CARE | Johnson & Johnson | Tennessee | local | 2007 | $45,913 | | property tax abatement |
Regeneron II(Mill Road) | Regeneron Pharmaceuticals | New York | local | 2003 | $46,350 | | tax credit/rebate; property tax abatement |
Regeneron Garage Addition 25 Discovery Dr. | Regeneron Pharmaceuticals | New York | local | 2020 | $46,384 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2010 | $46,571 | | tax credit/rebate |
EMERGENT PRODUCT DEVELOPMENT SEATTLE LLC | Emergent BioSolutions | Washington | state | 2012 | $47,245 | | tax credit/rebate |
Valeant Pharmaceuticals International | Bausch Health | North Carolina | state | 2013 | $47,287 | | tax credit/rebate |
Otsuka America, Inc. | Otsuka Pharmaceutical | Maryland | state | 2004 | $47,393 | | tax credit/rebate |
Astra Zeneca Pharmaceutical | AstraZeneca | Delaware | state | 2010 | $47,404 | | training reimbursement |
Bausch & Lomb | Bausch Health | Florida | state | 2012 | $47,493 | | training reimbursement |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2022 | $47,494 | | tax credit/rebate |
AbbVie, Inc. | AbbVie | Illinois | state | 2021 | $47,739 | | tax credit/rebate |
ABBOTT LABORATORIES | Abbott Laboratories | Ohio | state | 2008 | $47,957 | | grant |
Avid Radiopharmaceuticals, Inc. | Eli Lilly | Pennsylvania | state | 2010 | $48,077 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2011 | $48,189 | | tax credit/rebate; property tax abatement |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2020 | $48,205 | | tax credit/rebate |
Novo Nordisk, Inc. | Novo Holdings A/S | Pennsylvania | state | 2009 | $48,215 | | tax credit/rebate |
Johnson & Johnson | Johnson & Johnson | New York | local | 2006 | $48,224 | | tax credit/rebate; property tax abatement |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2013 | $48,418 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2014 | $48,418 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2015 | $48,418 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2013 | $48,688 | | tax credit/rebate; property tax abatement |
NewLink Genetics Corporation | Lumos Pharma | Iowa | state | 2007 | $49,130 | | training reimbursement |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2012 | $49,186 | | tax credit/rebate; property tax abatement |
Novo Nordisk Pharmaceuticals Industries, Inc. | Novo Holdings A/S | North Carolina | state | 2012 | $49,500 | | tax credit/rebate |
United Therapeutics Corporation | United Therapeutics | Maryland | state | 2021 | $49,887 | | tax credit/rebate |
Pfizer Inc. & Subsidiaries | Pfizer | Maryland | state | 2011 | $49,888 | | tax credit/rebate |
Alliance Pharma, Inc. | Alliance Pharma PLC | Pennsylvania | state | | $50,000 | | grant |
Bausch & Lomb | Bausch Health | Florida | state | 2010 | $50,000 | | training reimbursement |
Watson Pharmaceuticals | Teva Pharmaceutical Industries | Mississippi | state | 2012 | $50,000 | | training reimbursement |
MacroGenics, Inc. | MacroGenics | Maryland | local | | $50,000 | | grant/loan hybrid program |
Roche Diagnostics Operations, Inc. | Roche | Indiana | state | 2010 | $50,000 | | training reimbursement |
Albany Molecular Research, Inc. | Curia Inc. | Indiana | state | 2012 | $50,000 | | training reimbursement |
Abbott Laboratories | Abbott Laboratories | North Carolina | state | 2003 | $50,000 | | grant |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2010 | $50,043 | | tax credit/rebate; property tax abatement |
Sucampo Pharmaceuticals, Inc. | Mallinckrodt | Maryland | state | 2004 | $50,128 | | tax credit/rebate |
Mylan Technologies, Inc. | Viatris | Vermont | state | 2010 | $50,200 | | training reimbursement |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2012 | $50,570 | | tax credit/rebate |
Teva Biopharmaceuticals, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2014 | $50,570 | | tax credit/rebate |
C3I,Incorporated | Merck | New York | local | 2002 | $50,592 | | grant |
Amgen, Inc. | Amgen | Maryland | state | 2012 | $50,617 | | tax credit/rebate |
Amgen, Inc. | Amgen | Maryland | state | 2014 | $50,617 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2011 | $51,253 | | tax credit/rebate |
SEATTLE GENETICS INC | Seattle Genetics Inc. | Washington | state | 2010 | $51,253 | | tax credit/rebate |
Eli Lilly and Company | Eli Lilly | North Carolina | state | 2017 | $51,414 | | tax credit/rebate |
Lundbeck NA, Ltd. | Lundbeck | North Carolina | state | 2018 | $51,943 | | tax credit/rebate |
United Therapeutics Corp. | United Therapeutics | North Carolina | state | 2017 | $52,393 | | tax credit/rebate |
Shire Holdings US, AG | Takeda Pharmaceutical | Maryland | state | 2005 | $53,032 | | tax credit/rebate |
Ultragenyx Pharmaceutical Inc | Ultragenyx Pharmaceutical | Pennsylvania | state | 2021 | $53,100 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2012 | $53,148 | | tax credit/rebate |
Trevena, Inc. | Trevena Inc. | Pennsylvania | state | 2010 | $53,200 | | tax credit/rebate |
Emergent Biosolutions, Inc. | Emergent BioSolutions | Maryland | state | 2016 | $53,219 | | tax credit/rebate |
EMD Millipore | Merck KGaA (EMD) | New Hampshire | state | 2015 | $53,263 | | training reimbursement |
Synthes USA HQ, Inc. | Johnson & Johnson | Pennsylvania | state | 2009 | $53,661 | | tax credit/rebate |
Pfizer, Inc. | Pfizer | North Carolina | state | 2022 | $53,699 | | tax credit/rebate |
Teva Biopharmaceuticals USA, Inc. | Teva Pharmaceutical Industries | Maryland | state | 2015 | $53,885 | | tax credit/rebate |
IDEXX Operations Inc | IDEXX Laboratories | Maine | state | 2008 | $53,988 | | tax credit/rebate |
NOVO NORDISK INC | Novo Holdings A/S | Washington | state | 2009 | $53,997 | | tax credit/rebate |
Albany Molecular Research, Inc. | Curia Inc. | New York | state | 2011 | $54,000 | | enterprise zone |